san jose collage
San Jose
Serving San Jose, California (Santa Clara County)Vol. 1, No. 23
Medicine

Worried your bladder pills could raise your dementia risk?  A study of 830,000 adults found the older drugs were no riskier than the newer ones

Doctors have steered patients away from older overactive-bladder medicines over dementia fears.  The new study suggests the bladder problem itself may be an early sign of brain changes, but it can’t prove the drugs are risk-free.

ShareFacebookXEmail
Two oval tan tablets on a gray speckled surface, one showing an imprinted number on its face.
Myrbetriq (mirabegron) 50 mg tablets, one of the newer overactive-bladder drugs compared in the study. — Photo:  AntoineLaramee via Wikimedia Commons (CC BY-SA 4.0)

Older pills for overactive bladder, long suspected of raising the risk of dementia, were no riskier for the brain than newer drugs that doctors have been switching patients to, according to a study of 830,393 U.S. adults in JAMA Network Open.  Over 10 years, about 20% of patients who started on the newer drugs developed dementia, compared with about 18% of those who started on the riskiest-rated older drugs.

Overactive bladder causes a sudden, hard-to-control need to urinate.  It affects up to a third of adults and more than 40% of people over 60, the study says.  The older drugs, called anticholinergics, include oxybutynin, tolterodine and solifenacin.  They work by blocking a chemical messenger that also helps memory, which is why they came under suspicion.  The newer drugs, called beta-3 agonists, include mirabegron (sold as Myrbetriq) and vibegron.

What it means for you

If you take or are considering one of these medicines, the study suggests a short trial of an older drug is unlikely to cause lasting harm, lead author Dr. David Sheyn, a urogynecologist at University Hospitals Cleveland Medical Center, said in the hospital’s announcement.  The older drugs can still cause short-term memory and thinking side effects in some people, which go away when the drug is stopped, he said.  Sheyn cautioned that the results need to be repeated before guidelines change, and that the newer drugs are still considered the better choice when possible.  Talk with your doctor before switching or stopping.

The researchers suggest another explanation for past findings:  overactive bladder itself may be an early warning sign of the brain changes behind dementia, which can begin decades before memory problems appear.

How the study worked and its limits

The team used Epic Cosmos, a national database of electronic health records, to follow adults ages 40 to 90 who started treatment for overactive bladder from 2012 to 2025.  The study compared drug groups only.  It did not include people who took no medicine, so it cannot show the drugs carry no risk.  The authors also say small differences between groups could come from which patients doctors chose for each drug, since newer drugs may be given to people already seen as at risk.

Source:  Sheyn et al., “Drug Therapies and Incidence of Dementia Among Adults With Overactive Bladder,” JAMA Network Open, published Nov. 6, 2026 (PubMed Central); University Hospitals, “Study by UH Researchers Challenges Long Held Fears about Overactive Bladder Drugs and Dementia”.

Drafted by AI from the linked public source. Approved by a Daily News Editor.

Sources and documents